The Use of Vascular Endothelial Growth Factor Inhibitors in Patients with Proliferative Diabetic Retinopathy

V. Yu. Evgrafov; G. R. Kudasheva

Ophthalmology in Russia
Oftalʹmologiâ

ISSN 1816-5095 (Print)
ISSN 2500-0845 (Online)

User

eng | рус

Ophthalmology in Russia

Advanced search

Archives

Download this PDF file

Fullscreen

For citations:

Evgrafov V.Yu., Kudasheva G.R. The Use of Vascular Endothelial Growth Factor Inhibitors in Patients with Proliferative Diabetic Retinopathy. Ophthalmology in Russia. 2022;19(2):405-412. (In Russ.) https://doi.org/10.18008/1816-5095-2022-2-405-412

Views PDF (Rus): 702

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1816-5095 (Print)
ISSN 2500-0845 (Online)

* not an advertisement

Editor-in-Chief

Trubilin V.N

Indexing Databases

* not an advertisement

Article Tools

Finding References

Email this article (Login required)

Email the author (Login required)

About the Authors

V. Yu. Evgrafov
Pirogov Russian National Research Medical University
Russian Federation

MD, Professor, responsible for work with residents and postgraduates, Ophthalmology department of the school of continuing medical education,

Ostrovitianov str., 1, Moscow, 117997

G. R. Kudasheva
Pirogov Russian National Research Medical University
Russian Federation

postgraduate,

Ostrovitianov str., 1, Moscow, 117997

Notifications

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Ophthalmology in Russia

For citations:

Cookies policy